348 related articles for article (PubMed ID: 9536080)
21. Mutant protein in Huntington disease is resistant to proteolysis in affected brain.
Dyer RB; McMurray CT
Nat Genet; 2001 Nov; 29(3):270-8. PubMed ID: 11600884
[TBL] [Abstract][Full Text] [Related]
22. Huntington's disease does not appear to increase the risk of diabetes mellitus.
Boesgaard TW; Nielsen TT; Josefsen K; Hansen T; Jørgensen T; Pedersen O; Nørremølle A; Nielsen JE; Hasholt L
J Neuroendocrinol; 2009 Sep; 21(9):770-6. PubMed ID: 19602103
[TBL] [Abstract][Full Text] [Related]
23. Nuclear targeting of mutant Huntingtin increases toxicity.
Peters MF; Nucifora FC; Kushi J; Seaman HC; Cooper JK; Herring WJ; Dawson VL; Dawson TM; Ross CA
Mol Cell Neurosci; 1999 Aug; 14(2):121-8. PubMed ID: 10479410
[TBL] [Abstract][Full Text] [Related]
24. Evidence for a recruitment and sequestration mechanism in Huntington's disease.
Preisinger E; Jordan BM; Kazantsev A; Housman D
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1029-34. PubMed ID: 10434302
[TBL] [Abstract][Full Text] [Related]
25. Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation.
Wang J; Gines S; MacDonald ME; Gusella JF
BMC Neurosci; 2005 Jan; 6():1. PubMed ID: 15649316
[TBL] [Abstract][Full Text] [Related]
26. The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor.
Takano H; Gusella JF
BMC Neurosci; 2002 Oct; 3():15. PubMed ID: 12379151
[TBL] [Abstract][Full Text] [Related]
27. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
Bao J; Sharp AH; Wagster MV; Becher M; Schilling G; Ross CA; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):5037-42. PubMed ID: 8643525
[TBL] [Abstract][Full Text] [Related]
28. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
[TBL] [Abstract][Full Text] [Related]
29. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.
Wheeler VC; White JK; Gutekunst CA; Vrbanac V; Weaver M; Li XJ; Li SH; Yi H; Vonsattel JP; Gusella JF; Hersch S; Auerbach W; Joyner AL; MacDonald ME
Hum Mol Genet; 2000 Mar; 9(4):503-13. PubMed ID: 10699173
[TBL] [Abstract][Full Text] [Related]
30. Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain.
Toneff T; Mende-Mueller L; Wu Y; Hwang SR; Bundey R; Thompson LM; Chesselet MF; Hook V
J Neurochem; 2002 Jul; 82(1):84-92. PubMed ID: 12091468
[TBL] [Abstract][Full Text] [Related]
31. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking.
Orr AL; Li S; Wang CE; Li H; Wang J; Rong J; Xu X; Mastroberardino PG; Greenamyre JT; Li XJ
J Neurosci; 2008 Mar; 28(11):2783-92. PubMed ID: 18337408
[TBL] [Abstract][Full Text] [Related]
32. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
Martindale D; Hackam A; Wieczorek A; Ellerby L; Wellington C; McCutcheon K; Singaraja R; Kazemi-Esfarjani P; Devon R; Kim SU; Bredesen DE; Tufaro F; Hayden MR
Nat Genet; 1998 Feb; 18(2):150-4. PubMed ID: 9462744
[TBL] [Abstract][Full Text] [Related]
33. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
[TBL] [Abstract][Full Text] [Related]
34. The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.
Holbert S; Denghien I; Kiechle T; Rosenblatt A; Wellington C; Hayden MR; Margolis RL; Ross CA; Dausset J; Ferrante RJ; Néri C
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1811-6. PubMed ID: 11172033
[TBL] [Abstract][Full Text] [Related]
35. Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis.
Cong SY; Pepers BA; Roos RA; van Ommen GJ; Dorsman JC
Exp Neurol; 2006 Jun; 199(2):257-64. PubMed ID: 16380118
[TBL] [Abstract][Full Text] [Related]
36. Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment.
Muchowski PJ; Ning K; D'Souza-Schorey C; Fields S
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):727-32. PubMed ID: 11792857
[TBL] [Abstract][Full Text] [Related]
37. Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons.
Jackson GR; Salecker I; Dong X; Yao X; Arnheim N; Faber PW; MacDonald ME; Zipursky SL
Neuron; 1998 Sep; 21(3):633-42. PubMed ID: 9768849
[TBL] [Abstract][Full Text] [Related]
38. Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.
Zainelli GM; Ross CA; Troncoso JC; Fitzgerald JK; Muma NA
J Neurosci; 2004 Feb; 24(8):1954-61. PubMed ID: 14985437
[TBL] [Abstract][Full Text] [Related]
39. Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.
Weiss KR; Kimura Y; Lee WC; Littleton JT
Genetics; 2012 Feb; 190(2):581-600. PubMed ID: 22095086
[TBL] [Abstract][Full Text] [Related]
40. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded huntingtin and insoluble polymers.
Hoffner G; Island ML; Djian P
J Neurochem; 2005 Oct; 95(1):125-36. PubMed ID: 16181417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
